Evidence map›Paper›PMID 39148939›Full record

ArticleStem cells international2024

Circulating Gastric Cancer Stem Cells as Blood Screening and Prognosis Factor in Gastric Cancer.

Jared Becerril-Rico, Julian Grandvallet-Contreras, M Patricia Ruíz-León, Sebastián Dorantes-Cano, Lizbeth Ramírez-Vidal, José M Tinajero-Rodríguez, Elizabeth Ortiz-Sánchez

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Stem cells international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jared Becerril-RicoSubdirección de Investigación Básica Instituto Nacional de Cancerología, Secretaría de Salud, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-8550-275X
Julian Grandvallet-ContrerasSubdirección de Investigación Básica Instituto Nacional de Cancerología, Secretaría de Salud, Mexico City, Mexico.ORCID https://orcid.org/0000-0001-8021-070X
M Patricia Ruíz-LeónSubdirección de Investigación Básica Instituto Nacional de Cancerología, Secretaría de Salud, Mexico City, Mexico.ORCID https://orcid.org/0009-0001-9928-6795
Sebastián Dorantes-CanoSubdirección de Investigación Básica Instituto Nacional de Cancerología, Secretaría de Salud, Mexico City, Mexico.ORCID https://orcid.org/0009-0003-7240-9091
Lizbeth Ramírez-VidalPosgrado en Ciencias Biomédicas Universidad Nacional Autónoma de México Circuito Exterior s/n Ciudad Universitaria, Coyoacán, Mexico City 04510, Mexico.ORCID https://orcid.org/0009-0005-7018-6415
José M Tinajero-RodríguezSubdirección de Investigación Básica Instituto Nacional de Cancerología, Secretaría de Salud, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-4460-2906
Elizabeth Ortiz-SánchezSubdirección de Investigación Básica Instituto Nacional de Cancerología, Secretaría de Salud, Mexico City, Mexico.ORCID https://orcid.org/0000-0001-9855-9491

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer (GC) is the fourth leading cause of cancer-related death, associated with late diagnosis and treatment resistance. Currently, screening tests for GC are not cost-effective or have low accuracy. Previously, we described an extended phenotype of gastric cancer stem cells (GCSCs; CD24

Identifiers

PMID39148939
PMCPMC11326876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.